Introduction To
Hoodia Gordonii

The History Of Hoodia

Media Reports

How Hoodia works

Frequently Asked Questions

Hoodia Warning

More About The Hoodia Plant

Clinical Studies

Further Enquiries

Order Hoodia

The Hoodia Message Board



Hoodia Gordonii is known to contain a very special chemical compound, a steroidal glycoside, which enables the plant to act as an anorectic, an agent that suppresses appetite. It does this by inducing the sense of satiety in the brain, the sensation of fullness which leads the brain to switch off the desire for food. Having established that the Hoodia plant has this effect, and identifying the intriguing steroidal glycoside as the active ingredient in the plant, researchers then sought to establish exactly why and how the effect was caused.

Scientists studying Hoodia at Brown University in Rhode Island noticed that the steroidal glycoside it contains is similar in structure to a class of plant-derived compounds called cardiac glycosides. These substances are used to increase the force of contraction of the heart muscle and help maintain normal heart rate and rhythm, but they have a common side effect of loss of appetite, leading the researchers to feel that the actions of the Hoodia steroidal glycoside and the cardiac glycosides might be connected.

Cardiac glycosides act by stimulating a receptor molecule in the cells of the body called Na/K-ATPase, the function of which is to regulate the flow of sodium and potassium into and out of the cell using energy provided by a chemical called Adenosine Triphosphate (ATP). This process enables cells to perform muscle contraction, including heart muscle contraction, which is why cardiac glycosides are used for heart problems. But despite its similarities to these cardiac glycosides, studies on Hoodia's steroid glycoside failed to show any effect on the Na/K-ATPase receptor, indicating that the Hoodia's active ingredient appears not to act as a cardiac glycoside. The Hoodia compound also failed to show any effect on a wide range of other types of receptors, so at this time how it actually worked in the body was still a mystery.

The Brown researchers then tried a different approach and injected the steroidal glycoside directly into the brains of rats. The chosen location in the brain was the hypothalamus, the part of the brain controlling the body's basic functions, including appetite. The purpose of this was to determine whether the steroidal glycoside's appetite-suppressing effect was the result of direct action on the hypothalamus, and the answer to the question appeared to be yes. In multiple trials with the injected rats, food intake was reduced by 50–60% during the first 24 hours after the injections, and the effect, which was dose-dependent, lasted for about 24–48 hours.

The Brown researchers also discovered that the steroidal glycoside appeared to have more than doubled the level of the chemical Adenosine Triphosphate (ATP) in the hypothalamus. To test this further they put some rats on a restricted diet for 4 days, which decreased the ATP in the hypothalmus by 40%. This was understandable, because ATP is created in the body by the metabolism of food, so less food should result in less ATP. But when these underfed rats had the steroidal glycoside injected into their brains the ATP in the hypothalamus immediately rose to about normal.

The researchers had therefore shown that the steroidal glycoside does increase ATP levels in the hypothalamus. From this it seems reasonable to suggest that the mode of Hoodia's action in suppressing appetite appears to have been uncovered, that its active ingredient increases hypothalamic ATP and that this increased hypothalamic ATP is the key to inducing the sense of satiety in the brain.



The Phase 2 white kidney bean extract carb blocker is also known by the name of Phaseolamin 2250


Group 1 (500mg of Phase 2):

At the end of the study the results highlighted that the starch blockers determined an average weight loss of 2.933 kg (corresponding to 3.90% of total body weight). Such a weight loss also determined a 10.45% reduction of fat body mass, without any significant modification of lean body mass.

The results also highlighted that the product determined a 11.63% reduction of adipose membrane (by echography), a 3.44% reduction of waistline, a 1.39% reduction of hips circumference and a 1.44% reduction of thigh circumferences.

At the end of the study the results highlighted that the product determined an average weight loss of 0.348 kg (corresponding to 0.47% of total body weight) without any significant modification of fat body mass or of lean body mass.

The results also highlighted that the product determined a 1.30% reduction of adipose membrane (by echography), a 0.53% reduction of waistline, a 0.10% reduction of hips circumference and a 0.39% reduction of thigh circumferences.

The results suggest that the placebo did not determine any significant modifications of the considered parameters, while the 500mg of Phase 2 tablets demonstrated a good efficacy in a reduction of calories intake from complex carbohydrates for an easier, correct and balanced weight loss (calculated by impedance measure), with a reduction of adipose membrane thickness (echography) and a reduction of waistline, hips circumference and thigh circumferences.

It should also be stressed that in this study the food supplement was administered when it was known that a meal of high complex carbohydrate content was to follow, and that complex carbohydrates can be absorbed only after enzymatic parting through pancreatic amylases.

The weight loss, particularly of fat body mass, can be attributed to a lower absorption of complex carbohydrates, due to the activity of the vegetal glycoprotein included in the tablets taken before the meal. weight loss lose losing




Hoodia Gordonii action page Last Updated 06/05/08 20:36:57 UK

You are Visitor No: